ALS/MND Natural History Study Data Repository
NCT05966038 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-05-20
Summary
This is a data repository for multi-site multi-protocol clinic-based Natural History Study of ALS and Other Motor Neuron Disorders (MND).
All people living with ALS or other MNDs who attend clinics at the Study hospitals (sites) are offered to participate in the Study.
The Sites collect so-called Baseline information including demographics, disease history and diagnosis, family history, etc. At each visit, the Sites also collect multiple disease-specific outcome measures and events. The information is captured in NeuroBANK, a patient-centric clinical research platform.
The Sites have an option to choose to collect data into 20+ additional forms capturing biomarkers and outcome measures. Captured data after its curation are anonymized (all personal identifiers and dates are being removed), and the anonymized dataset is shared with medical researchers via a non-exclusive revocable license.
Funding Source - Biogen, Inc.; Mitsubishi Tanabe Pharma America; FDA OOPD.
Conditions
- ALS
- PLS
- MND (Motor Neurone DIsease)
- Kennedy Disease
- PMA - Progressive Muscular Atrophy
- PBP - Progressive Bulbar Palsy
Sponsors & Collaborators
-
Henry Ford Health System
collaborator OTHER - collaborator OTHER
-
Temple University
collaborator OTHER -
St. Louis University
collaborator OTHER -
University of Florida
collaborator OTHER - collaborator OTHER
-
Virginia Commonwealth University
collaborator OTHER -
Fondazione Serena Onlus - Centro Clinico NeMO Milano
collaborator OTHER -
Providence Health & Services
collaborator OTHER -
University of Pittsburgh
collaborator OTHER -
Istituti Clinici Scientifici Maugeri SpA
collaborator OTHER -
Lahey Clinic
collaborator OTHER -
Hadassah Medical Organization
collaborator OTHER -
Tel Aviv Medical Center
collaborator OTHER - collaborator OTHER
-
Trinity Health Michigan
collaborator OTHER -
Thomas Jefferson University
collaborator OTHER -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Alexander Sherman · Massachusetts General Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-01
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- United States
- Israel
- Italy
Study Locations
More Related Trials
-
Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project
NCT06820008 ·Status: RECRUITING
-
DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida
NCT01699451 ·Status: COMPLETED
-
Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org
NCT00302198 ·Status: COMPLETED
-
A Study to Evaluate the Performance of a Diagnostic Test in ALS
NCT02759913 ·Status: UNKNOWN
-
Study of Predictive Factors of Progression of Motor Neurone Disease
NCT02360891 ·Status: COMPLETED
-
Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral Sclerosis
NCT04953494 ·Status: UNKNOWN
-
EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)
NCT00718458 ·Status: COMPLETED
-
Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
NCT01459302 ·Status: WITHDRAWN
-
Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers.
NCT02044029 ·Status: COMPLETED
-
Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS
NCT05747937 ·Status: RECRUITING ·Phase: NA
-
Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry
NCT07143656 ·Status: ACTIVE_NOT_RECRUITING
-
Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis
NCT01992029 ·Status: TERMINATED
-
Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
NCT03366506 ·Status: RECRUITING
-
Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis
NCT04455542 ·Status: COMPLETED
-
Home-based Remote Digital Monitoring to Assess ALS Progression (Track ALS)
NCT05276349 ·Status: COMPLETED
-
Serial Fasciculation Measurements in Motor Neurone Disease
NCT03809845 ·Status: COMPLETED ·Phase: NA
-
Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.
NCT05852418 ·Status: RECRUITING
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
NCT05663008 ·Status: RECRUITING
-
Longitudinal Data Collection in Pediatric and Adult Patients With Spinal Muscular Atrophy in Latin America
NCT05475691 ·Status: ACTIVE_NOT_RECRUITING
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
NCT02327845 ·Status: ENROLLING_BY_INVITATION
-
COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry
NCT04559009 ·Status: COMPLETED
-
Amyotrophic Lateral Sclerosis (ALS) Families Project
NCT03865420 ·Status: RECRUITING
-
Speech Analysis in ALS Patients
NCT03868345 ·Status: COMPLETED